Literature DB >> 25211238

Autonomic system and amyotrophic lateral sclerosis.

Ezequiel A Piccione1, David M Sletten, Nathan P Staff, Phillip A Low.   

Abstract

INTRODUCTION: The aim of this study is to characterize autonomic impairment in motor neuron disease.
METHODS: Neurological evaluations and autonomic testing were analyzed retrospectively in 132 patients: 86 classic amyotrophic lateral sclerosis (ALS), 36 lower motor neuron (LMN), and 10 upper motor neuron (UMN) predominant disease.
RESULTS: One-third of patients were symptomatic; urinary urgency and constipation were the most frequent symptoms. Increased Composite Autonomic Severity Score (CASS) was present in 75% with mild impairment (CASS 1-3) in 85% and moderate (CASS 4-7) in 15%. The frequencies of testing abnormalities were: sudomotor 46%, cardiovagal 50%, and adrenergic 14%. The UMN group had significantly higher median CASS scores than the classic ALS (P = 0.021) and LMN group (P = 0.018).
CONCLUSIONS: We found predominantly mild autonomic impairment in ALS patients, with mostly cardiovagal and sudomotor involvement. Moderate autonomic failure occurred in 1 of 7 patients, especially those with an UMN presentation. Patients with selective corticospinal tract involvement may have more impairment of autonomic pathways.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Composite Autonomic Severity Score; amyotrophic lateral sclerosis; autonomic impairment; motor neuron disease; sudomotor

Mesh:

Year:  2015        PMID: 25211238      PMCID: PMC4362936          DOI: 10.1002/mus.24457

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  21 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Involvement of Onuf's nucleus in amyotrophic lateral sclerosis.

Authors:  T Kihira; S Yoshida; F Yoshimasu; I Wakayama; Y Yase
Journal:  J Neurol Sci       Date:  1997-03-20       Impact factor: 3.181

3.  Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis.

Authors:  K Chida; S Sakamaki; T Takasu
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

4.  Small-fiber neuropathy in patients with ALS.

Authors:  J Weis; I Katona; G Müller-Newen; C Sommer; G Necula; C Hendrich; A C Ludolph; A-D Sperfeld
Journal:  Neurology       Date:  2011-06-07       Impact factor: 9.910

5.  A quantitative study of intermediolateral column cells in motor neuron disease and the Shy-Drager syndrome.

Authors:  P G Kennedy; L W Duchen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

6.  Sympathetic sudomotor function and amyotrophic lateral sclerosis.

Authors:  M Santos-Bento; M de Carvalho; T Evangelista; M L Sales Luís
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2001-06

7.  Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  J J Figueroa; P J B Dyck; R S Laughlin; J A Mercado; R Massie; P Sandroni; P J Dyck; P A Low
Journal:  Neurology       Date:  2012-02-22       Impact factor: 9.910

8.  Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure.

Authors:  P A Low
Journal:  Mayo Clin Proc       Date:  1993-08       Impact factor: 7.616

Review 9.  Autonomic nervous system function.

Authors:  P A Low
Journal:  J Clin Neurophysiol       Date:  1993-01       Impact factor: 2.177

10.  Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis.

Authors:  Georg S Nübling; Eva Mie; Ricarda M Bauer; Mira Hensler; Stefan Lorenzl; Alexander Hapfelmeier; Debra E Irwin; Gian Domenico Borasio; Andrea S Winkler
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-01-31       Impact factor: 4.092

View more
  13 in total

1.  Cutaneous somatic and autonomic nerve TDP-43 deposition in amyotrophic lateral sclerosis.

Authors:  Yuting Ren; Wenxiu Liu; Yifan Li; Bo Sun; Yanran Li; Fei Yang; Hongfen Wang; Mao Li; Fang Cui; Xusheng Huang
Journal:  J Neurol       Date:  2018-05-26       Impact factor: 4.849

Review 2.  Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis.

Authors:  Carlayne E Jackson; April L McVey; Stacy Rudnicki; Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

3.  Robot-assisted total gastrectomy for gastric cancer in a patient with amyotrophic lateral sclerosis receiving long-term tracheostomy invasive ventilation.

Authors:  Masaaki Nishi; Ryosuke Miyamoto; Kasane Shima; Hirokazu Miki; Hideo Terasawa; Chie Takasu; Kozo Yoshikawa; Takuro Oyama; Katsuya Tanaka; Yuishin Izumi; Mitsuo Shimada
Journal:  Int Cancer Conf J       Date:  2021-07-12

4.  Reliability of autonomic activations as surrogates of cortical arousals in ventilated patients affected by amyotrophic lateral sclerosis.

Authors:  Grazia Crescimanno; Francesca Greco; Salvatore Arrisicato; Oreste Marrone
Journal:  Sleep Breath       Date:  2018-07-24       Impact factor: 2.816

Review 5.  Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Colin J Mahoney; Rebekah M Ahmed; William Huynh; Sicong Tu; Jonathan D Rohrer; Richard S Bedlack; Orla Hardiman; Matthew C Kiernan
Journal:  CNS Drugs       Date:  2021-05-15       Impact factor: 5.749

Review 6.  Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis.

Authors:  Jik Nijssen; Laura H Comley; Eva Hedlund
Journal:  Acta Neuropathol       Date:  2017-04-13       Impact factor: 17.088

7.  Inflammatory Gene Expression in Whole Peripheral Blood at Early Stages of Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Pol Andrés-Benito; Jesús Moreno; Raúl Domínguez; Ester Aso; Mónica Povedano; Isidro Ferrer
Journal:  Front Neurol       Date:  2017-10-13       Impact factor: 4.003

8.  Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015.

Authors:  Jaime Raymond; BjÖrn Oskarsson; Paul Mehta; Kevin Horton
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-05-26       Impact factor: 4.092

9.  FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis.

Authors:  Jessica Mandrioli; Amedeo Amedei; Giovanni Cammarota; Elena Niccolai; Elisabetta Zucchi; Roberto D'Amico; Federica Ricci; Gianluca Quaranta; Teresa Spanu; Luca Masucci
Journal:  Front Neurol       Date:  2019-09-20       Impact factor: 4.003

10.  Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.

Authors:  Masaru Tanaka; József Toldi; László Vécsei
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.